 |
Amazon
PROSTATE SUPPORT*
120 capsules (650 mg each)
Buy Now
|
|
A synergistic formula of 9 rainforest botanicals to nutritionally support prostate function.* For more information on the individual ingredients in Amazon Prostate Support, follow the links provided below to the plant database files in the Tropical Plant Database.
Each rainforest botanical in this professional formula has been sustainably harvested in the Amazon Rainforest. Click here to learn more about our rainforest ingredients and wild harvesting methods. This product contains no binders, fillers, or exipients and is 100% finely milled natural plants. This product is backed by Raintree's Unconditional Guarantee.
Ingredients: A proprietary blend of nettle, jatoba, mutamba, graviola, Brazilian peppertree, vassourinha, cipó cabeludo, pau d'arco, and anamu. This formula is 100% pure natural ground plants. No binders, fillers or other additives are used. These plants have grown naturally in the richness of the Amazon without any pesticides or fertilizers and they are non-irradiated and non-fumigated.
Suggested Use: Take 2-3 capsules 2-3 times daily.
Contraindications: None known.
Drug Interactions: None known.
Other Practitioner Observations:
- Several plants in this formula have demonstrated antimicrobial activity in laboratory tests. Long term use may lead to die-off of friendly bacteria in the digestive tract. Supplementation with probiotics and digestive enzymes is advisable when this formula is used for longer than 30 days.
- Cipó cabeludo contains the plant chemical coumarin which has anticoagulant activity. Those on anticoagulant medications, or those with blood disorders such as hemophilia, should be monitored closely for this blood-thinning effect.
- Several plants in this formula have been documented to reduce blood pressure in animal studies. Individuals with low blood pressure should be monitored for this possible effect.
A 120 capsule bottle is $29.95 each
Or buy 3 bottles for $28.95 each
Or buy 6 bottles for $26.95 each
Buy Now
Print a PDF Amazon Prostate Support Brochure
Please note that this is a professional product offered by health practitioners and it is not available in retail stores. Click here to see a list of practitioners who use our products.
|
|
Third-Party Published Research*
This proprietary Raintree product has not been the subject of any clinical research. A partial listing of third-party published research on each herbal ingredient in the formula is shown below. Please refer to the plant database files by clicking on the plant names below to see all available documentation and research on each plant ingredient.
Nettle Root (Urtica dioica)
Popa, G., et al. “Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic
hyperplasia. Results of a placebo-controlled double-blind study.” MMW Fortschr. Med. 2005 Oct; 147 Suppl
3:103-8.
Lopatkin, N., et al. “Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract
symptoms—a placebo-controlled, double-blind, multicenter trial.” World J. Urol. 2005 Jun; 23(2): 139-46.
Walther, C., et al. “Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant
preparation." MMW Fortschr Med. 2005 Oct; 147(40):52-3.
Popa, G., et al. “Benign prostate syndrome: urinary tract symptoms can be eased with phytotherapy.” MMW
Fortschr. Med. 2005 Aug; 147(33-34):42.
Schneider, T., et al. “Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome
(BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months” Urologe A.
2004 Mar;43(3):302-6.
Durak I, et al. “Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in
prostate tissue from patients with prostate cancer.” Cancer Biol. Ther. 2004; 3(9): 855-7.
Carson, C., et al. “The role of dihydrotestosterone in benign prostatic hyperplasia.” Urology. 2003; 61(4 Suppl 1):
2-7.
Melo, E. A., et al. “Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica
dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial.”
Int. Braz. J. Urol. 2002 Sep-Oct; 28(5): 418-25.
Koch, E. “Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable
alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts
symptoms.” Planta Med. 2001; 67: 489-500.
Sokeland, J. “Combined sabal and urtica extract compared with finasteride in men with benign prostatic
hyperplasia: analysis of prostate volume and therapeutic outcome.” B. J. U. Int. 2000; 86(4): 439-42.
Schottner, M., et al. “Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone
binding globulin (SHBG).” Planta Med. 1997; 63(6): 529-32.
Lichius, J. J., et al. “The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic
hyperplasia in the mouse.” Planta Med. 1997; 63(4): 307-10.
Hryb, D. J., et al. “The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG
with its receptor on human prostatic membranes.” Planta Med. 1995; 61(1): 31-2.
Koch E. and A. Biber. "Pharmacological effects of saw palmetto and urtica extracts for benign prostatic
hyperplasia." Urologe 1994; 34(2): 90-95.
Krzeski, T., et al. “Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic
hyperplasia: double-blind comparison of two doses.” Clin. Ther. 1993; 15(6): 1011-20.
Jatobá (Hymenaea courbaril)
Abdel-Kader, M., et al. “Isolation and absolute configuration of ent-Halimane diterpenoids from Hymenaea courbaril
from the Suriname rain forest.” J. Nat. Prod. 2002; 65(1): 11-5.
Rahalison, L., et al. “Screening for antifungal activity of Panamanian plants.” Inst. J. Pharmacog. 1993; 31(1):
68–76.
Verpoorte, R., et al. “Medicinal plants of Surinam. IV. Antimicrobial activity of some medicinal plants.” J.
Ethnopharmacol. 1987; 21(3): 315–18.
Arrhenius, S.P., et al. “Inhibitory effects of Hymenaea and Copaifera leaf resins on the leaf fungus, Pestalotia
subcuticulari.” Biochem. Syst. Ecol. 1983; 11(4): 361–66.
Tincusi, B. M., et al. “Antimicrobial terpenoids from the oleoresin of the Peruvian medicinal plant Copaifera
paupera.” Planta Med. 2002; 68(9): 808–12.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatomucosal infections. 1: Screening of 38
plant extracts.” J. Ethnopharmacol. 1991; 33(3): 277–83.
Verpoorte, R., et al. “Medicinal plants of Surinam. IV. Antimicrobial activity of some medicinal plants.” J.
Ethnopharmacol. 1987; 21(3): 315–18.
Mutamba (Guazuma ulmifolia)
Camporese, A., et al. “Screening of anti-bacterial activity of medicinal plants from Belize (Central America).” J.
Ethnopharmacol. 2003 Jul; 87(1): 103-7.
Navarro, M. C., et al. “Antibacterial, antiprotozoal and antioxidant activity of five plants used in Izabal for infectious
diseases.” Phytother. Res. 2003; 17(4): 325-9.
Caceres, A., et al. “Anti-gonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted
diseases.” J. Ethnopharmacol. 1995; 48(2): 85–88.
Caceres, A., et al. “Plants used in Guatemala for the treatment of gastrointestinal disorders. 3. Confirmation of
activity against enterobacteria of 16 plants.” J. Ethnopharmacol. 1993; 38(1): 31–38.
Caceres, A., et al. “Plants used in Guatemala for the treatment of respiratory diseases. 2: Evaluation of activity of
16 plants against gram-positive bacteria.” J. Ethnopharmacol. 1993; 39(1): 77–82.
Heinrich, M., et al. “Parasitological and microbiological evaluation of Mixe Indian medicinal plants.” (Mexico) J.
Ethnopharmacol. 1992; 36(1): 81–85.
Caceres, A., et al. “Plants used in Guatemala for the treatment of gastrointestinal disorders. 1. Screening of 84
plants against enterobacteria.” J. Ethnopharmacol. 1990; 30(1): 55–73.
Caceres, A., et al. “Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of
dermatomucosal diseases.” J. Ethnopharmacol. 1987; 20(3): 223–37.
Graviola (Annona muricata)
Takahashi, J. A., et al. “Antibacterial activity of eight Brazilian Annonaceae plants.” Nat. Prod. Res. 2006; 20(1):21-6
Betancur-Galvis, L., et al. “Antitumor and antiviral activity of Colombian medicinal plant extracts.” Mem. Inst. Oswaldo Cruz 1999; 94(4): 531-35.
Antoun, M. D., et al. “Evaluation of the flora of Puerto Rico for in vitro cytotoxic and anti-HIV activities.
Pharmaceutical Biol. 1999; 37(4): 277-280.
Sundarrao, K., et al. “Preliminary screening of antibacterial and antitumor activities of Papua New Guinean native
medicinal plants.” Int. J. Pharmacog. 1993; 31(1): 3–6.
Misas, C. A. J., et al. “Contribution to the biological evaluation of Cuban plants. IV.” Rev. Cubana Med. Trop. 1979;
31(1): 29–35.
Yuan, S. S., et al. “Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and
causes cytotoxicity in a Bax- and caspase-3-related pathway.” Life Sci. 2003 May: 72(25): 2853-61.
Brazilian Peppertree (Schinus molle)
de Lima, M. R., et al. “Anti-bacterial activity of some Brazilian medicinal plants.” J. Ethnopharmacol. 2005 Dec 12;
Schmourlo, G., et al. “Screening of antifungal agents using ethanol precipitation and bioautography of medicinal
and food plants.” J. Ethnopharmacol. 2005 Jan; 96(3): 563-8.
de Carvalho, M. C. “Evaluation of mutagenic activity in an extract of pepper tree stem bark (Schinus terebinthifolius
Raddi).” Environ. Mol. Mutagen. 2003; 42(3): 185-91.
de Melo, Jr., E. J., et al. “Medicinal plants in the healing of dry socket in rats: Microbiological and microscopic
analysis.” Phytomedicine. 2002; 9(2): 109–16.
Quiroga, E. N., et al. “Screening antifungal activities of selected medicinal plants.” J. Ethnopharmacol. 2001; 74(1):
89–96.
Martinez, M. J., et al. “Screening of some Cuban medicinal plants for antimicrobial activity.” J. Ethnopharmacol.
1996; 52(3): 171–74.
Cuella, M. J., et al. “Two fungal lanostane derivatives as phospholipase A2 inhibitors.” J. Nat. Prod. 1996; 59(10):
977–79.
Gundidza, M., et al. “Antimicrobial activity of essential oil from Schinus molle Linn.” Central African J. Med. 1993;
39(11): 231–34.
Dikshit, A. “Schinus molle: a new source of natural fungitoxicant.” Appl. Environ. Microbiol. 1986; 51(5): 1085–88.
El-Keltawi, N., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Herba Pol. 1980; 26(4): 245–50.
Ross, S., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Fitoterapia. 1980; 51: 201–5.
Vassourinha (Scoparia dulcis)
Kasperczyk, H., et al. “Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for
cancer therapy.” Oncogene. 2005 Oct; 24(46): 6945-56.
Fulda, S., et al. “Sensitization for anticancer drug-induced apoptosis by betulinic acid.” Neoplasia. 2005; 7(2):
162-70.
Garg, A. K., et al. “Chemosensitization and radiosensitization of tumors by plant polyphenols.” Antioxid. Redox.
Signal. 2005; 7(11-12): 1630-47.
Ahmed, M., et al. “Analgesic, diuretic, and anti-inflammatory principle from Scoparia dulcis.” Pharmazie. 2001;
56(8): 657–60.
Freire, S., et al. “Analgesic and anti-inflammatory properties of Scoparia dulcis L. extracts and glutinol in rodents.”
Phytother. Res. 1993; 7: 408–14.
Freire, S., et al. “Analgesic activity of a triterpene isolated from Scoparia dulcis (vassourinha).” Mem. Inst. Oswaldo
Cruz. 1991; 86 (Suppl. II): 149–51.
Ratnasooriya, W. D., et al. “Antioxidant activity of water extract of Scoparia dulcis.” Fitoterapia. 2005 Mar; 76(2):
220-2.
Babincova, M., et al. “Free radical scavenging activity of Scoparia dulcis extract.” J. Med. Food. 2001; 4(3): 179-181.
Arisawa, M. “Cell growth inhibition of KB cells by plant extracts.” Natural Med. 1994; 48(4): 338–47.
Nishino, H. “Antitumor-promoting activity of scopadulcic acid B, isolated from the medicinal plant Scoparia dulcis
L." Oncology. 1993; 50(2): 100–3.
Cipó Cabeludo (Mikania hirsutissima)
Ohkoshi, E., et al. “ent-Kaurenoic acids from Mikania hirsutissima (Compositae).” Phytochemistry. 2004 Apr;
65(7): 885-90.
Wilkins, M., et al. “Characterization of the bactericidal activity of the natural diterpene kaurenoic acid.” Planta Med.
2002; 68(5): 452–54.
Davino, S. C., et al. “Antimicrobial activity of kaurenoic acid derivatives substituted on carbon-15.” Braz. J. Med.
Biol. Res. 1989; 22(9): 1127–29.
de Souza, C. P., et al. “Chemoprophylaxis of schistosomiasis: molluscacidal activity of natural products—assays
with adult snails and oviposition.” An. Acad. Bras. Cienc. 1984; 56(3): 333–38.
Suyenaga, E. S., et al. "Anti-inflammatory investigation of some species of Mikania." Phytother. Res. 2002; 16(6):
519-23.
Paiva, L. A., et al. “Anti-inflammatory effect of kaurenoic acid, a diterpene from Copaifera langsdorffi on acetic
acid-induced colitis in rats.” Vascul. Pharmacol. 2002 Dec; 39(6): 303-7.
Pau d'arco (Tabebuia impetiginosa)
Lee, J. H., et al. “Down-regulation of cyclooxygenase-2 and telomerase activity by beta-lapachone in human
prostate carcinoma cells.” Pharmacol. Res. 2005; 51(6): 553-60.
Choi, Y. H., et al. “Suppression of human prostate cancer cell growth by beta-Lapachone via down-regulation of
PRB phosphorylation and induction of Cdk Inhibitor p21(WAF1/CIP1).” J. Biochem. Mol. Biol. 2003 Mar; 36(2):
223-9.
Balassiano, I. T., et al. “Demonstration of the lapachol as a potential drug for reducing cancer metastasis. Oncol.
Rep. 2005; 13(2): 329-33.
Park, B. S., et al. “Selective growth-inhibiting effects of compounds identified in Tabebuia impetiginosa inner bark
on human intestinal bacteria.” J. Agric. Food Chem. 2005 Feb; 23;53(4): 1152-7.
Park, B. S., et al. “Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter
pylori.” J. Ethnopharmacol. 2005 Dec;
Machado, T. B., et al. “In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their
analogues, against methicillin-resistant Staphylococcus aureus.” Int. J. Antimicrob. Agents. 2003; 21(3): 279-84.
Portillo, A., et al. “Antifungal activity of Paraguayan plants used in traditional medicine.” J. Ethnopharmacol. 2001;
76(1): 93–8.
Nagata, K., et al. “Antimicrobial activity of novel furanonaphthoquinone analogs.” Antimicrobial Agents Chemother.
1998; 42(3): 700–2.
Binutu, O. A., et al. “Antimicrobial potentials of some plant species of the Bignoniaceae family.” Afr. J. Med. Sci.
1994; 23(3): 269–73.
Giuraud, P., et al. “Comparison of antibacterial and antifungal activities of lapachol and b-lapachone.” Planta Med.
1994; 60: 373–74.
Anesini, C., et al. “Screening of plants used in Argentine folk medicine for antimicrobial activity.” J. Ethnopharmacol.
1993; 39(2): 119–28.
Anamu (Petiveria alliacea)
Gomes, P. B., et al. “Study of antinociceptive effect of isolated fractions from Petiveria alliacea L. (tipi) in mice.” Biol.
Pharm. Bull. 2005; 28(1): 42-6.
Lopes-Martins, R. A., et al. “The anti-inflammatory and analgesic effects of a crude extract of Petiveria alliacea L.
(Phytolaccaceae).” Phytomedicine. 2002; 9(3): 245-48.
Dunstan, C. A., et al. “Evaluation of some Samoan and Peruvian medicinal plants by prostaglandin biosynthesis
and rat ear oedema assays.” J. Ethnopharmacol. 1997 Jun; 57(1): 35-56.
Kim, S., et al. “Antibacterial and antifungal activity of sulfur-containing compounds from Petiveria alliacea L.” J.
Ethnopharmacol. 2005 Oct 13;
Kubec, R., et al. “The lachrymatory principle of Petiveria alliacea.” Phytochemistry. 2003 May; 63(1): 37-40.
Ruffa, M. J., et al. “Antiviral activity of Petiveria alliacea against the bovine diarrhea virus. Chemotherapy 2002;
48(3): 144-47.
Benevides, P. J., et al. “Antifungal polysulphides from Petiveria alliacea L.” Phytochemistry. 2001; 57(5): 743-7.
Jovicevic, L., et al. “In vitro antiproliferative activity of Petiveria alliacea L. on several tumor cell lines.” Pharmacol.
Res. 1993; 27(1): 105-06.
Rossi, V., et al. “Antiproliferative effects of Petiveria alliacea on several tumor cell lines.” Pharmacol. Res. Suppl.
1990; 22(2): 434.
|
* The statements contained herein have not been evaluated
by the Food and Drug Administration.
This product is
not intended to treat, cure, mitigate or prevent any disease.
Please refer to our Conditions of Use for this web site and product.
Thank you for your support and
for choosing a Raintree product!
Raintree Nutrition, Inc.
3579 Hwy 50 East, Suite 222
Carson City, NV 89701
(800) 780-5902
(775) 841-4142
(775) 841-4022 Fax
Return to Main Product Page
    
© Copyrighted 1996
to present by Raintree Nutrition, Inc., Carson City, NV 89701. All rights reserved.
Please read the Conditions of Use, Copyright Statement and our Privacy Policy for this web page and web site.
Updated 12-31-06
|